Can Procter & Gamble Stock Skyrocket?
When it comes to consumer goods some items are an…
Sell
2
TECX Quote, Financials, Valuation and Earnings
Last price:
$25.29
Seasonality move
:
-8.25%
Day range:
$24.50 - $26.18
52-week range:
$13.80 - $61.07
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.48x
Volume:
269.5K
Avg. volume:
508.1K
1-year change:
59.68%
Market cap:
$373.2M
Revenue:
--
EPS (TTM):
-$3.45
Earnings Data
Next earnings date for TECX
May 30
2025
Most recent earnings per share
-$1.20
Missed by $1.20
(Nov 12/2024)
Consensus Estimate
--
(Nov 12/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
TECX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 05/30/2025 | Q1 | -- | -- | -- | -- | -- |
| 02/28/2025 | Q4 | -- | -- | -- | -- | -- |
| 11/12/2024 | Q3 | -- | -- | -$1.20 | -- | -- |
| 08/14/2024 | Q2 | -- | -- | -$0.86 | -- | -- |
| 09/30/2023 | Q3 | -- | -- | -$0.68 | -- | -- |
| 06/30/2023 | Q2 | -- | -- | -$0.71 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$0.70 | -- | -- |
Tectonic Therapeutic Earnings Questions
-
How Much did Tectonic Therapeutic Generate in Revenue Last Quarter?
Tectonic Therapeutic reported -- worth of top line sales in its most recent quarter.
-
Did Tectonic Therapeutic Beat Earnings Last Quarter?
Tectonic Therapeutic announced earnings per share of -$1.20 which represents a miss of analyst forecast a -- per share.
-
Is Tectonic Therapeutic Profitable?
Tectonic Therapeutic reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Tectonic Therapeutic EPS Next Year?
Tectonic Therapeutic's earnings are forecast to decrease from -- per share to -- per share next year representing a decrease of -237.91%.
-
When is Tectonic Therapeutic's Earnings Date?
Tectonic Therapeutic's next earnings date is May 30, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tempus AI Stock a Buy Now?
Tempus AI (NASDAQ:TEM) has seen its stock run all over…
Is Palantir Stock Overhyped?
At one point, it seemed like the software giant Palantir…
Stock Ideas
Buy
61
Is AAPL Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 40x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3T
P/E Ratio: 42x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3T
P/E Ratio: 34x
Alerts
Sell
10
PRAX alert for Mar 1
Praxis Precision Medicines [PRAX] is down 40.97% over the past day.
Sell
22
ACHC alert for Mar 1
Acadia Healthcare [ACHC] is down 25.48% over the past day.
Buy
75
GRRR alert for Mar 1
Gorilla Technology Group [GRRR] is up 21.83% over the past day.
